세계의 인공혈관 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Persistence Market Research presents an in-depth analysis of the Artificial Blood Vessels Market, offering insights into its intricate dynamics and future trajectory. From market trends to growth catalysts, impediments, and emerging patterns, this report furnishes invaluable statistics and projections spanning from 2024 to 2031.

Key Insights:

• Artificial Blood Vessels Market Size (2024): USD 2.1 Bn
• Projected Market Value (2031): USD 2.9 Bn
• Global Market Growth Rate (CAGR 2024 to 2031):4.1%

Artificial Blood Vessels Market - Report Scope:

The Artificial Blood Vessels Market encompasses a wide range of applications in cardiovascular surgeries, dialysis procedures, and vascular grafting. These vessels play a vital role in replacing or bypassing damaged or blocked blood vessels, providing life-saving solutions for patients with severe vascular conditions. Artificial blood vessels are integral to procedures requiring vascular reconstruction, arteriovenous fistulas, and peripheral artery bypass surgeries. This market serves hospitals, specialty clinics, and ambulatory surgical centers, delivering solutions that enhance surgical success rates and patient outcomes. Market growth is driven by factors such as advancements in biomaterials, an aging population, and the prevalence of vascular diseases.

Market Growth Drivers:

The global Artificial Blood Vessels Market is bolstered by several key growth drivers. Innovations in biomaterials and tissue engineering enhance the durability, biocompatibility, and functionality of artificial vessels, promoting widespread adoption in the healthcare sector. Moreover, the rising incidence of cardiovascular diseases and chronic kidney diseases has significantly increased the demand for vascular grafting procedures. Additionally, an aging global population, coupled with the growing prevalence of lifestyle-related vascular conditions such as atherosclerosis and diabetes, has further fueled market demand. These trends are catalyzing investments in research and development to produce next-generation artificial blood vessels.

Market Restraints:

Despite its promising growth trajectory, the Artificial Blood Vessels Market faces challenges related to high production costs, regulatory hurdles, and limited long-term clinical data. The significant costs associated with manufacturing artificial blood vessels, particularly those incorporating advanced biomaterials or tissue engineering, can limit their affordability and accessibility in lower-income regions. Furthermore, stringent regulatory requirements for approval, combined with the need for extensive clinical trials to establish safety and efficacy, pose hurdles to market entry. Lastly, concerns regarding long-term performance and potential complications, such as thrombosis or infection, necessitate further research and refinement of existing technologies.

Market Opportunities:

The Artificial Blood Vessels Market presents lucrative growth opportunities driven by technological innovation, rising healthcare investments, and expanding applications. Emerging trends in nanotechnology, 3D bioprinting, and customized vascular grafts are inspiring manufacturers to develop more advanced and patient-specific solutions. Strategic partnerships between medical device companies and research institutions facilitate the development of innovative products and accelerate market penetration. Moreover, increased healthcare funding, particularly in emerging economies, provides a supportive environment for market growth. Expanding applications in pediatric vascular surgeries and minimally invasive procedures further broaden the market scope.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Artificial Blood Vessels Market globally?
• How are advancements in biomaterials and tissue engineering shaping the evolution of artificial blood vessels?
• What are the key challenges and opportunities facing market participants in the artificial blood vessel segment?
• Which healthcare sectors and geographic regions offer the highest growth potential for artificial blood vessel manufacturers?
• What strategies are leading companies employing to differentiate their artificial blood vessel offerings and capture market share in a competitive landscape?

Competitive Intelligence and Business Strategy:

Leading players in the global Artificial Blood Vessels Market, including medical device manufacturers, biotechnology firms, and research institutions, focus on innovation, product differentiation, and strategic expansion to gain a competitive edge. These companies invest in research and development to advance biomaterials and manufacturing techniques, improving the biocompatibility and longevity of artificial blood vessels. Moreover, collaborations with academic and clinical partners enable market players to accelerate product development and access cutting-edge technologies. Emphasis on regulatory compliance, quality assurance, and post-market surveillance further strengthens brand reputation and fosters trust among healthcare providers and patients.

Key Companies Profiled:

• Braun Melsungen
• Becton
• Dickinson and Company
• Cook Medical Incorporated
• Medtronic
• LeMaitre Vascular Inc.
• Terumo Medical Corporation
• W. L. Gore and Associates
• Jotec GmbH
• Humacyte Inc.
• Techshot Inc.

Artificial Blood Vessels Market Research Segmentation:

By Polymer Type

• Polydioxanone
• Elastomer
• Polyethylene Terephthalate
• Others

By Application

• Aortic Disease
• Peripheral Artery Disease
• Hemodialysis

By End User

• Hospitals
• Cardiac Catheterization Laboratories
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region

North America

Europe

East Asia

South Asia and Oceania

Latin America

Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Artificial Blood Vessels Market Snapshot, 2024 and 2031
• 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overviews

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
  • 2.3.3. Global Healthcare Spending Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Type Adoption Analysis
• 3.2. Value Chain Analysis
  • 3.2.1. List of End User/Marketplaces
    • 3.2.1.1. Retail
    • 3.2.1.2. E-commerce
  • 3.2.2. List of End User (Industry)
• 3.3. Key Deals and Mergers
• 3.4. PESTLE Analysis
• 3.5. Porter's Five Force Analysis

4. Global Artificial Blood Vessels Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
• 4.3. Global Artificial Blood Vessels Market Outlook: Polymer Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Polymer Type, 2019 - 2023
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Type, 2024 - 2031
    • 4.3.3.1. Polydioxanone
    • 4.3.3.2. Elastomer
    • 4.3.3.3. Polyethylene Terephthalate
    • 4.3.3.4. Others
  • 4.3.4. Market Attractiveness Analysis: Polymer Type
• 4.4. Global Artificial Blood Vessels Market Outlook: Application
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
  • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 4.4.3.1. Aortic Disease
    • 4.4.3.2. Peripheral Artery Disease
    • 4.4.3.3. Hemodialysis
  • 4.4.4. Market Attractiveness Analysis: Application
• 4.5. Global Artificial Blood Vessels Market Outlook: End User
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 4.5.3.1. Hospitals
    • 4.5.3.2. Cardiac Catheterization Laboratories
    • 4.5.3.3. Ambulatory Surgical Centers
    • 4.5.3.4. Specialty Clinics
    • 4.5.3.5. Others
  • 4.5.4. Market Attractiveness Analysis: End User

5. Global Artificial Blood Vessels Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Artificial Blood Vessels Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 6.2.1. By Country
  • 6.2.2. By Polymer Type
  • 6.2.3. By Application
  • 6.2.4. By End User
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Type, 2024 - 2031
  • 6.4.1. Polydioxanone
  • 6.4.2. Elastomer
  • 6.4.3. Polyethylene Terephthalate
  • 6.4.4. Others
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 6.5.1. Aortic Disease
  • 6.5.2. Peripheral Artery Disease
  • 6.5.3. Hemodialysis
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 6.6.1. Hospitals
  • 6.6.2. Cardiac Catheterization Laboratories
  • 6.6.3. Ambulatory Surgical Centers
  • 6.6.4. Specialty Clinics
  • 6.6.5. Others
• 6.7. Market Attractiveness Analysis

7. Europe Artificial Blood Vessels Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 7.2.1. By Country
  • 7.2.2. By Polymer Type
  • 7.2.3. By Application
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Type, 2024 - 2031
  • 7.4.1. Polydioxanone
  • 7.4.2. Elastomer
  • 7.4.3. Polyethylene Terephthalate
  • 7.4.4. Others
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 7.5.1. Aortic Disease
  • 7.5.2. Peripheral Artery Disease
  • 7.5.3. Hemodialysis
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 7.6.1. Hospitals
  • 7.6.2. Cardiac Catheterization Laboratories
  • 7.6.3. Ambulatory Surgical Centers
  • 7.6.4. Specialty Clinics
  • 7.6.5. Others
• 7.7. Market Attractiveness Analysis

8. East Asia Artificial Blood Vessels Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 8.2.1. By Country
  • 8.2.2. By Polymer Type
  • 8.2.3. By Application
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Type, 2024 - 2031
  • 8.4.1. Polydioxanone
  • 8.4.2. Elastomer
  • 8.4.3. Polyethylene Terephthalate
  • 8.4.4. Others
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 8.5.1. Aortic Disease
  • 8.5.2. Peripheral Artery Disease
  • 8.5.3. Hemodialysis
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 8.6.1. Hospitals
  • 8.6.2. Cardiac Catheterization Laboratories
  • 8.6.3. Ambulatory Surgical Centers
  • 8.6.4. Specialty Clinics
  • 8.6.5. Others
• 8.7. Market Attractiveness Analysis

9. South Asia and Oceania Artificial Blood Vessels Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 9.2.1. By Country
  • 9.2.2. By Polymer Type
  • 9.2.3. By Application
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Type, 2024 - 2031
  • 9.4.1. Polydioxanone
  • 9.4.2. Elastomer
  • 9.4.3. Polyethylene Terephthalate
  • 9.4.4. Others
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 9.5.1. Aortic Disease
  • 9.5.2. Peripheral Artery Disease
  • 9.5.3. Hemodialysis
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 9.6.1. Hospitals
  • 9.6.2. Cardiac Catheterization Laboratories
  • 9.6.3. Ambulatory Surgical Centers
  • 9.6.4. Specialty Clinics
  • 9.6.5. Others
• 9.7. Market Attractiveness Analysis

10. Latin America Artificial Blood Vessels Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 10.2.1. By Country
  • 10.2.2. By Polymer Type
  • 10.2.3. By Application
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Type, 2024 - 2031
  • 10.4.1. Polydioxanone
  • 10.4.2. Elastomer
  • 10.4.3. Polyethylene Terephthalate
  • 10.4.4. Others
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 10.5.1. Aortic Disease
  • 10.5.2. Peripheral Artery Disease
  • 10.5.3. Hemodialysis
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 10.6.1. Hospitals
  • 10.6.2. Cardiac Catheterization Laboratories
  • 10.6.3. Ambulatory Surgical Centers
  • 10.6.4. Specialty Clinics
  • 10.6.5. Others
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Artificial Blood Vessels Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 11.2.1. By Country
  • 11.2.2. By Polymer Type
  • 11.2.3. By Application
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Polymer Type, 2024 - 2031
  • 11.4.1. Polydioxanone
  • 11.4.2. Elastomer
  • 11.4.3. Polyethylene Terephthalate
  • 11.4.4. Others
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 11.5.1. Aortic Disease
  • 11.5.2. Peripheral Artery Disease
  • 11.5.3. Hemodialysis
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 11.6.1. Hospitals
  • 11.6.2. Cardiac Catheterization Laboratories
  • 11.6.3. Ambulatory Surgical Centers
  • 11.6.4. Specialty Clinics
  • 11.6.5. Others
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Braun Melsungen
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Becton
  • 12.3.3. Dickinson and Company
  • 12.3.4. Cook Medical Incorporated
  • 12.3.5. Medtronic
  • 12.3.6. LeMaitre Vascular Inc.
  • 12.3.7. Terumo Medical Corporation
  • 12.3.8. W. L. Gore and Associates
  • 12.3.9. Jotec GmbH
  • 12.3.10. Humacyte Inc.
  • 12.3.11. Techshot Inc.

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations